Interim Guidelines for the Management and Administration of the AstraZeneca (ChAdOx1-S [recombinant]) COVID-19 Vaccine

Category: 

2019-nCoV Interim Guidelines

Date: 

Thursday, March 4, 2021

Document Type: 

Department Memorandum 2021-0123

File: 

dm2021-0123.pdf